Chief Medical Officer of Keros Therapeutics, Inc. (NASDAQ:KROS), Ordonez Claudia, sells 1,000 shares worth $59,926

According to Keros Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Apr 14 04:46 PM, company Chief Medical Officer, Ordonez Claudia disclosed selling 1,000 shares at a cost of $59.93. At the time of this transaction (Apr 12), this trade was worth $59,926 in total. As of Apr 12, Ordonez Claudia now owns 0 shares in total worth about $0.0.

For the last few recent trades made by Keros Therapeutics, Inc. (NASDAQ:KROS) Chief Medical Officer, Ordonez Claudia, we have the following information:

Posted by George Daniels on Wednesday April 14 2021, 7:20 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0